Abstract:The question, "Can aging be modified, delayed, or reversed?" has profound social and economic implications for rapidly aging societies today. Interventions, ideally, would intercept functional decline and extend healthspan by delaying late-life morbidity (known as "squaring the curve"). These have proven elusive, but examples of differential aging in the animal world abound, suggesting aging itself is a malleable process. We present a novel multi-scale theoretical framework for entropic aging, and apply it to recently published DNA methylation data from 348 evolutionarily distant mammalian species. Our analysis identified modules or correlated DNA methylation changes associated with reversible pathway activation in key biological processes. We discovered a single species-dependent scaling factor controlling the magnitude of fluctuations across biological pathways. It acts as the organism's "effective temperature", quantifying intrinsic biological noise within networks and is unrelated to physical body temperature. Furthermore, we find a distinct stochastic damage signature and an associated extreme value (Gumbel) distribution of activation barriers controlling site-specific damage rates of individual CpG sites. This implies that aging is driven by rare, high-energy transitions on rugged energy landscape, most likely simultaneous and hence practically irreversible failures in highly redundant systems. While the overall rate of damage accumulation and hence the maximum lifespan does not depend on the effective temperature driving the noise in leading pathways, effective temperature does influence both initial mortality rate and the mortality rate doubling time -- thereby shaping the survival curve. Lowering effective temperature must, therefore, be a promising Geroscience strategy, aimed directly at squaring the curve of aging. The example shows that targeting the thermodynamic forces driving mammalian aging may provide powerful strategies for the development of truly meaningful interventions to combat aging in humans.

Targeting multiple hallmarks of mammalian aging with combinations of interventions

Combinatorial interventions in aging

Common Pathogenetic Mechanisms Underlying Aging and Tumor and Means of Interventions.

HOW MANY MOLECULAR MECHANISMS MUST BE ALTERED SIMULTANEOUSLY TO SLOW AGING AND EXTEND LIFESPAN?

Interactions between mitochondrial dysfunction and other hallmarks of aging: Paving a path toward interventions that promote healthy old age

Comprehensive Insights from Molecular Targets and Biomarkers to Biological Clocks

Molecular mechanisms of aging and anti-aging strategies

Clinical Trials Targeting Aging

Antiaging agents: safe interventions to slow aging and healthy life span extension

Candidate molecular targets uncovered in mouse lifespan extension studies

Targeting the Mitochondria-Proteostasis Axis to Delay Aging

Transcriptomic Hallmarks of Mortality Reveal Universal and Specific Mechanisms of Aging, Chronic Disease, and Rejuvenation

Multi-Omic Rejuvenation: A New Strategy for Lifespan Extension

Targeting Senescent Cells for a Healthier Longevity: the Roadmap for an Era of Global Aging

Aging Biomarkers and Novel Targets for Anti-Aging Interventions.

Focus on senescence: Clinical significance and practical applications

Discovery of Thermodynamic Control Variables that Independently Regulate Healthspan and Maximum Lifespan

Methods for the discovery of new anti-aging products – targeted approaches

Translatability of life‐extending pharmacological treatments between different species

Key Molecular Mechanisms of Aging, Biomarkers, and Potential Interventions

Comparable anti-ageing efficacies of a multi-ingredient nutraceutical and a senolytic intervention in old mice